Merck to Hold Investor Briefing at 2016 ASCO Annual Meeting

Dateline City:

KENILWORTH, N.J.

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada,
announced today that Dr. Roger M. Perlmutter, president, Merck Research
Laboratories, will present an overview of the company’s oncology program
at the 52nd Annual Meeting of the American Society of Clinical Oncology
(ASCO) in Chicago on June 6, 2016 at 5:45 p.m. CDT (6:45 p.m. EDT).

Language:

English

Contact:

MerckMedia:Lainie Keller, [phone]orInvestor:Teri Loxam, [phone]orJustin Holko, [phone]

Ticker Slug:

Ticker: MRK Exchange: NYSE

read more

Source: Merck.com - Corporate News - June 1, 2016 Category: Pharmaceuticals Tags: Corporate News Financial News Latest News #Merck #MRK $MRK ASCO MSD Source Type: news